Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Nab-paclitaxel Venous Injection Plus Transcatheter Arterial Infusion in Advanced Pancreatic Cancer
NCT06196788Phase 2Recruiting
- Sponsor
- Fudan University
- Start
- Mar 2024
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, paclitaxel in pancreatic cancer (PC), sponsored by Fudan University. Started Mar 2024; status: recruiting.
02
Drugs
gemcitabinepaclitaxel
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT06196788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06196788.